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Red cell distribution width (RDW) is associated with mortality and bloodstream infection risk
in the critically ill. In vascular surgery patients surviving critical care it is not known if RDW
can predict subsequent risk of all-cause mortality following hospital discharge. We hypothe-
sized that an increase in RDW at hospital discharge in vascular surgery patients who
received critical care would be associated with increased mortality following hospital
discharge.
Design, setting, and participants
We performed a two-center observational cohort study of critically ill non-cardiac vascular
surgery patients surviving admission 18 years or older treated between November, 1997,
and December 2012 in Boston, Massachusetts.
Exposures
RDW measured within 24 hours of hospital discharge and categorized a priori as13.3%,
13.3–14.0%, 14.0–14.7%, 14.7–15.8%, >15.8%.
Main outcomes and measures
The primary outcome was all cause mortality in the 90 days following hospital discharge.
Results
The cohort included 4,715 patients (male 58%; white 83%; mean age 62.9 years). 90 and
365-day post discharge mortality was 7.5% and 14.4% respectively. In the cohort, 47.3%
were discharged to a care facility and 14.8% of patients were readmitted within 30 days.
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After adjustment for age, gender, race, Deyo-Charlson comorbidity Index, patient type,
acute organ failures, prior vascular surgery and vascular surgery category, patients with a
discharge RDW 14.7–15.8% or >15.8% have an adjusted OR of 90-day post discharge mor-
tality of 2.52 (95%CI, 1.29–4.90; P = 0.007) or 5.13 (95%CI, 2.70–9.75; P <0.001) relative to
patients with a discharge RDW13.3%. The adjusted odds of 30-day readmission in the
RDW >15.8% group was 1.52 (95%CI, 1.12–2.07; P = 0.007) relative to patients with a dis-
charge RDW13.3%. Similar adjusted discharge RDW-outcome associations are present
at 365 days following hospital discharge and for discharge to a care facility.
Conclusions
In critically ill vascular surgery patients who survive hospitalization, an elevated RDW at hos-
pital discharge is a strong predictor of subsequent mortality, hospital readmission and place-
ment in a care facility. Patients with elevated RDW are at high risk for adverse out of hospital
outcomes and may benefit from closer post discharge follow-up and higher intensity
rehabilitation.
Introduction
Survivors of critical illness suffer from significant long-term morbidity and mortality [1]. Post-
hospital discharge mortality in intensive care unit (ICU) survivors is over 15% at one year and
near 40% at three years [2, 3]. Little is known about the post-hospital survival for critically ill
vascular surgery patients in general or the specific risk factors for adverse outcomes in this
population. The existing studies on risk factors and predictive models of outcomes following
vascular surgery are not focused on those requiring critical care [4–7].
Inflammation is central for the initiation and propagation of vascular disease [8]. Vascular
surgery patients have high inflammatory activation as surgery induces additional pro-
inflammatory cytokines [9]. Inflammatory mediators correlate with Red cell distribution
width (RDW), a measure of the variation in circulating red cell size commonly reported in the
complete blood count [10–12]. RDW is robustly associated with markers of chronic subclinical
inflammation, elevated oxidative stress, malnutrition, C-reactive protein, interleukin-6, eryth-
rocyte sedimentation rate and beta-natriuretic peptide [10–13]. Patients with elevated RDW
have a significantly higher risk of peripheral artery disease [14, 15], hypertension [16], and cor-
onary artery disease event rates [17].
Our prior cohort studies in medical and surgical patients demonstrate that RDW is also
associated with critical illness outcomes when measured at hospital admission and at hospital
discharge [18, 19]. Our critical illness outcome studies did not focus on the vascular surgery
population where RDW is associated with vascular disease presence [14–17]. As the vascular
surgery population has increased complications, mortality and readmissions following hospital
discharge [20], we sought to determine the relationship between RDW at hospital discharge
and post-hospital outcomes in vascular surgery patients who required critical care. We
hypothesized that elevated RDW at hospital discharge would be associated with increased all
cause 90-day post-hospital discharge mortality. To test this hypothesis, we performed a two-
center observational cohort study of 4,715 adults who underwent vascular surgery and were
treated with critical care and survived hospitalization.
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Materials and methods
Source population
We extracted administrative and laboratory data from patients admitted to two Boston hospi-
tals: Brigham and Women’s Hospital (BWH), with 777 beds and Massachusetts General Hos-
pital (MGH) with 999 beds. The two hospitals provide primary as well as tertiary care to an
ethnically and socioeconomically diverse population within eastern Massachusetts and the sur-
rounding region.
Data sources
Data on all patients admitted to BWH or MGH between November 2, 1997 and December 31,
2012 were obtained through the Research Patient Data Registry (RPDR), a computerized regis-
try which serves as a central data warehouse for all inpatient and outpatient records at Partners
HealthCare sites which includes BWH and MGH. The RPDR has been used for other clinical
research studies [18, 19, 21, 22]. This study was approved by the Partners Human Research
Committee, the Institutional Review Board (IRB) of Partners HealthCare. Informed consent of
study subjects was not obtained. The IRB approval included a waiver of the requirement to
obtain informed consent because the risk to study subjects, including risk to privacy, was
deemed to be minimal, obtaining informed consent of study subjects was not feasible and the
rights and welfare of the subjects would not be adversely affected by the waiver.
Study population
During the study period there were 7,608 unique patients, age 18 years, who received critical
care, were assigned Current Procedural Terminology (CPT) codes for vascular surgery in the
six days prior to ICU admission to 2 days after (S1 Appendix), and were assigned a Diagnostic
Related Group code. ICU admission was determined by assignment of the CPT code 99291
(critical care, first 30–74 minutes) during hospitalization admission, a validated approach for
ICU admission in the RPDR database [23]. Exclusions included: 3 patients who had white
blood cells over 150,000/μl as a high white blood cell count may skew the automatically calcu-
lated RDW [24]; 961 patients who died as in-patients; 76 patients with End Stage Renal Dis-
ease; and 1,853 patients who did not have RDW drawn within 24 hours of hospital discharge.
Thus, 4,715 patients constituted the total study population.
Exposure of interest and comorbidities
The exposure of interest was RDW within 24 hours of hospital discharge and categorized a pri-
ori as13.3%, 13.3–14.0%, 14.0–14.7%, 14.7–15.8%, and>15.8%. For the duration of the
study, the RDW was determined directly from the red blood cell histogram and expressed as
coefficient of variation (CV) via automated hematology analyzers. Sepsis was defined as the
presence of International Classification of Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM) codes 038, 995.91, 995.92, or 785.52, 3 days prior to critical care initiation to
7 days after critical care initiation [25]. We utilized the Deyo-Charlson index to assess the bur-
den of chronic illness [26] employing ICD-9-CM coding algorithms which are well studied
and validated [27, 28]. History of hypertension was identified using ICD-9-CM codes (401.0,
401.1, 401.9, 405, 405.01, 405.09, 405.1, 405.11, 405.19, 405.9, 405.91, and 405.99) [29]. Patient
Type is defined as Medical or Surgical and incorporates the Diagnostic Related Grouping
(DRG) methodology [30] and is published by the Centers for Medicare & Medicaid Services
(CMS) [31]. Number of organs with failure was adapted from Martin et al [32] and defined by
a combination of ICD-9-CM and Current Procedural Terminology (CPT) codes relating to
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acute organ dysfunction assigned from 3 days prior to critical care initiation to 30 days after
critical care initiation [33, 34]. Noncardiogenic acute respiratory failure was identified by the
presence of ICD-9-CM codes for respiratory failure or pulmonary edema (518.4, 518.5, 518.81,
and 518.82) and mechanical ventilation (96.7×), excluding congestive heart failure (428.0–
428.9) following hospital admission [24]. Changes from the expected hospital length of stay
(LOS) were computed as the difference between the actual LOS and the geometric mean LOS
for each DRG as determined by the Centers for Medicare & Medicaid Services [13].
Patients were considered to have exposure to inotropes and vasopressors if pharmacy rec-
ords in the 3 days prior to the 7 days after critical care initiation showed evidence of the use of
dopamine, dobutamine, epinephrine, norepinephrine, phenylephrine, milrinone or vasopres-
sin. As adding exogenous red blood cells through repeated transfusions is reported to skew the
RDW [24], transfusion data was obtained via blood bank reports. The number of packed red
blood cell units transfused in the 48 hours prior to critical care initiation through the hospital
stay was recorded.
Assessment of mortality
Information on vital status for the study cohort was obtained from the Social Security Admin-
istration Death Master File. The accuracy of the Social Security Administration Death Master
File for in-hospital and out of hospital mortality in our administrative database is validated
[23]. 100% of the cohort had vital status present at 365 days following hospital discharge.
Study outcomes
The primary outcome was all-cause 90-day post-discharge mortality. Secondary outcomes
included 365-day post-discharge mortality, unplanned 90-day hospital readmission [35, 36]
and discharge to a care facility. Hospital readmission was determined from RPDR hospital
admission data as previously described [37] and defined as a subsequent or unscheduled
admission to BWH or MGH following the index hospitalization associated with the critical
care exposure [37–39]. We excluded readmissions with DRG codes that are commonly associ-
ated with planned readmissions in addition to DRGs for transplantation, procedures related to
pregnancy, and psychiatric issues [3, 37]. Discharge care facility data was determined from
hospital records [40].
Power calculations and statistical analysis
Based on our prior work [19], we assume that absolute 90-day post-hospital discharge mortal-
ity will increase 12.7% in patients with discharge RDW>15.8% compared to those with dis-
charge RDW13.3%. Using Stata 14.1MP statistical software (College Station, TX), we
estimated the sample size for two-sample comparison of proportions. With an alpha error
level of 5% (two-sided) and a power of 90%, the sample size thus required for our primary end
point (90-day post-hospital discharge mortality) is 114 in the RDW>15.8% group and 114 in
the RDW13.3% group.
Categorical variables were described by frequency distribution, and compared across RDW
groups using contingency tables and chi-square testing. Continuous variables were examined
graphically (histogram, box plot) and in terms of summary statistics (mean, standard devia-
tion, median, interquartile range), and then compared across exposure groups using one-way
analysis of variance (ANOVA). Unadjusted associations between covariates and mortality
were estimated by bivariable logistic regression models. Adjusted odds ratios were estimated
by multivariable logistic regression models with inclusion of a priori determined covariate
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terms thought to plausibly associate with both RDW levels and 90-day post-discharge mortal-
ity. Overall model fit was assessed using the Hosmer Lemeshow test.
We assessed possible effect modification of sepsis, creatinine, white blood count, hematocrit
and transfusion on the risk of mortality using the likelihood-ratio test. We evaluated for con-
founding by individually running the adjusted model with and without terms for creatinine,
white blood count, transfusion, hematocrit, vasopressors/inotropes or mechanical ventilation.
Receiver operator characteristic (ROC) curves were constructed to analyze the discriminating
power of discharge RDW for predicting 90-day post-discharge mortality, and the areas
under each ROC curve were compared. An empirical estimation of the optimal ROC cutoff
point was performed with the cutpt command in Stata utilizing bootstrapping [41]. The con-
tinuous crude and adjusted relationship between discharge RDW level and risk of 90-day
post-discharge mortality was graphically represented utilizing the coefplot command [42]. All
p-values are two-tailed, with values<0.05 were considered statistically significant. All analyses
were performed using Stata 14.1MP statistical software (College Station, TX).
Results
Table 1 shows characteristics of the study population. Most patients were male (58%), white
(83%) and the majority had surgically related DRGs (84%). The mean age at hospital admis-
sion was 62.6 (SD 16.9) years. Post-hospital discharge mortality rates were 3.9% at 30-days,
7.5% at 90 days and 14.4% at 365 days. 90-day readmission rate was 23%. The vascular surgery
procedure classes in the cohort included abdomen (36%), amputations (2%), compartment
syndrome (2%), lower extremity (8%), neck (8%), upper extremity (31%) and venous (13%).
Fifty-four percent of the vascular procedures were endovascular. Age, Deyo-Charlson Index,
acute organ failure, malignancy, acute kidney injury, sepsis, RDW at hospital discharge,
change in expected length of stay, discharge to care facility and hospital readmission are signif-
icant predictors of 90-day mortality (Table 1).
Patient characteristics of the study cohort were stratified according to discharge RDW levels
(Table 2).
Most factors significantly differed between stratified groups including 90-day post-dis-
charge mortality.
Primary outcome
RDW at hospital discharge was a strong predictor of 90-day post-discharge mortality following
multivariable adjustment for relevant confounders (Fig 1 and Table 3).
In model 1 adjusting for age, race, patient type, Deyo-Charlson index, Number of organs
with acute failure, sepsis, prior vascular surgery and vascular surgery class, the odds of 90-day
mortality in the RDW 14.7–15.8% and RDW >15.8% groups was 5 and 12-fold higher than
the RDW 13.3% group respectively. Discharge RDW remained a significant predictor of
odds of mortality after adjustment for age, gender, race, DRG type, Deyo-Charlson index,
acute organ failure, sepsis, prior vascular surgery and vascular surgery category. The adjusted
odds of 90-day mortality in the RDW 14.7–15.8% and RDW >15.8% groups was 2.5 and
5-fold respectively that of those with RDW 13.3%. The AUC for the prediction model 1 for
90 day post-discharge mortality was 0.80 (95%CI 0.78–0.83). The prediction model 1 showed
good calibration (HL χ2 9.2, P = 0.33) (Table 3). The optimal cut point for 90-day post-dis-
charge mortality was RDW = 15.45 (95%CI 15.01–15.88).
There was no significant effect modification of the RDW-90-day post-discharge mortality
association on the basis of sepsis (P-interaction = 0.23), hospital (P-interaction = 0.09), chronic
kidney disease (P-interaction = 0.52) or transfusion (P-interaction = 0.48). Though the effect
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sizes differed, the direction of the estimates and overall significance of the RDW-post-dis-
charge mortality association was not materially altered by hospital. Additional adjustment of
the model for hospital, endovascular repair, calendar quarter of hospital discharge or Red
Blood Cell Transfusions did not materially alter the point estimates. Similar robust crude and
adjusted discharge RDW-mortality associations are present at 365 days following hospital dis-
charge (data not shown).
Secondary outcomes
The adjusted odds of 90-day readmission in the RDW 14.7–15.8% and RDW>15.8% groups
was 1.9 and 2.1 fold higher respectively that of those with RDW 13.3% (Table 4).







P-value Unadjusted OR (95%CI) for 90-day Post Discharge Mortality
Age years-mean±SD 61.8 ± 16.9 71.9 ± 13.2 62.6 ± 16.9 <0.001† 1.05 (1.04, 1.06)
Male Gender-no.(%) 2,528 (58) 194 (55) 2,722 (58) 0.25 0.88 (0.71, 1.09)
Non-White Race-no.(%) 768 (18) 52 (15) 820 (17) 0.16 0.81 (0.59, 1.09)
Surgical Patient Type-no.(%) 3,666 (84) 296 (84) 3,962 (84) 0.83 0.97 (0.72, 1.30)
Prior Vascular Surgery-no.(%) 529 (12) 50 (14) 579 (12) 0.27 1.19 (0.87, 1.63)
Deyo-Charlson index-no.(%) <0.001
0–1 1,012 (23) 25 (7) 1,037 (22) 1.00 (Referent)
2–3 1,914 (44) 104 (29) 2,018 (43) 2.20 (1.41, 3.43)
4–6 1,230 (28) 179 (51) 1,409 (30) 5.89 (3.84, 9.03)
7 205 (5) 46 (13) 251 (5) 9.08 (5.46, 15.12)
Number of organs with acute failure-no.(%) <0.001
0 1,309 (30) 48 (14) 1,357 (29) 1.00 (Referent)
1 1,546 (35) 124 (35) 1,670 (35) 2.19 (1.55, 3.08)
2 950 (22) 107 (30) 1,057 (22) 3.07 (2.16, 4.36)
3 385 (9) 52 (15) 437 (9) 3.68 (2.45, 5.54)
4 171 (4) 23 (7) 194 (4) 3.67 (2.18, 6.18)
Malignancy-no.(%) 731 (17) 136 (38) 867 (18) <0.001 3.10 (2.47, 3.89)
Hypertension-no.(%) 976 (22) 39 (11) 1,015 (22) <0.001 0.43 (0.31, 0.60)
Acute Kidney Injury-no.(%) b 247 (7) 38 (14) 285 (7) <0.001 2.38 (1.65, 3.43)
Sepsis-no.(%) 188 (4) 31 (9) 219 (5) <0.001 2.13 (1.43, 3.17)
Noncardiogenic acute respiratory failure-no.(%) 387 (9) 30 (8) 417 (9) 0.80 0.95 (0.64, 1.40)
Vasopressors/Inotropes-no.(%) 2,203 (51) 167 (47) 2,370 (50) 0.23 0.88 (0.70, 1.09)
Acute Organ Failure Score-mean±SD c 8.0 ± 3.8 10.8 ± 3.6 8.2 ± 3.8 <0.001† 1.20 (1.17, 1.24)
RDW at Hospital Discharge-mean±SD 14.8 ± 1.7 16.2 ± 2.1 14.9 ± 1.8 <0.001† 1.38 (1.31, 1.44)








<0.001‡ 1.02 (1.02, 1.03)
Discharge to Care Facility-no.(%) 1,991 (89) 235 (11) 2,226 (47) <0.001 2.35 (1.87, 2.95)
90-Day Readmission-no.(%) 965 (22) 121 (34) 1,086 (23) <0.001 1.83 (1.45, 2.30)
Data presented as no. (%) unless otherwise indicated. P determined by chi-square except for † determined by ANOVA or ‡ determined by Kruskal-Wallis test.
a. Expired within 90-days following hospital discharge
b. Acute Kidney Injury is RIFLE class injury or failure and available on 3,989 patients.
c. The Acute Organ Failure score is a severity of illness risk-prediction score ranging from 0–30 points with 30 having the highest risk for mortality
https://doi.org/10.1371/journal.pone.0199654.t001
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Further, the adjusted odds of discharge to a facility rather than to home (i.e., rehabilitation
and long-term acute care) in the RDW 14.7–15.8% and RDW> 15.8% groups was 1.7 and 2.1
fold higher, respectively, compared with RDW 13.3% group (Table 4).
Discussion
The main finding of our study is the graded relationship between increased RDW at hospital
discharge in vascular surgery patients who survive critical care and adverse outcomes follow-
ing hospital discharge. Elevated RDW at hospital discharge is significantly associated with
90-day mortality following adjustment for potential confounders. Further, discharge RDW is
associated with placement in a care facility and 90-day unplanned hospital readmission.
Table 2. Patient characteristics by RDW category group.
Characteristic Discharge RDW
13.3 13.3–14.0 14.0–14.7 14.7–15.8 >15.8 P-value
N 692 1,023 885 949 1,166
Age-mean±SD 55.72 ± 17.83 61.92 ± 16.39 64.43 ± 16.56 63.91 ± 17.23 62.57 ± 16.87 <0.001†
Male Gender-no.(%) 454 (66) 624 (61) 502 (57) 544 (57) 2,722 (58) <0.001
Non-White Race-no.(%) 122 (18) 164 (16) 148 (17) 170 (18) 820 (17) 0.59
Surgical Patient Type-no.(%) 488 (71) 828 (81) 780 (88) 848 (89) 3,962 (84) <0.001
Prior Vascular Surgery-no.(%) 52 (8) 98 (10) 110 (12) 128 (13) 191 (16) <0.001
Endovascular-no.(%) 442 (64) 599 (59) 458 (52) 436 (46) 614 (53) <0.001
Deyo-Charlson index-no.(%) <0.001
0–1 269 (39) 260 (25) 171 (19) 186 (20) 151 (13)
2–3 328 (47) 477 (47) 408 (46) 400 (42) 405 (35)
4–6 87 (13) 255 (25) 264 (30) 309 (33) 494 (42)
7 8 (1) 31 (3) 42 (5) 54 (6) 116 (10)
Number of organs with acute failure -no.(%) <0.001
0 348 (50) 390 (38) 243 (27) 182 (19) 194 (17)
1 248 (36) 396 (39) 328 (37) 318 (34) 380 (33)
2 69 (10) 174 (17) 216 (24) 282 (30) 316 (27)
3 23 (3) 50 (4.89) 70 (8) 116 (12) 178 (15)
4 4 (1) 13 (1) 28 (3) 51 (5) 98 (8)
Malignancy-no.(%) 73 (11) 140 (14) 143 (16) 197 (21) 314 (27) <0.001
Hypertension-no.(%) 94 (14) 202 (20) 216 (24) 219 (23) 284 (24) <0.001
Acute Kidney Injury-no.(%) 12 (2) 25 (3) 38 (5) 67 (9) 143 (15) <0.001
Sepsis-no.(%) 4 (1) 15 (1) 22 (2) 55 (6) 219 (5) <0.001
Noncardiogenic acute respiratory failure -no.(%) 36 (5) 72 (7) 71 (8) 105 (11) 417 (9) <0.001
Vasopressors/Inotropes -no.(%) 237 (34) 483 (47) 438 (49) 548 (58) 2,370 (50) <0.001
Acute Organ Failure Score-mean±SD 6.61 ± 3.53 7.43 ± 3.58 8.12 ± 3.55 8.75 ± 3.79 8.23 ± 3.83 <0.001
Change in Expected Length of Stay-median[IQR] 1.4 [-1.4, 4.4] 2.4 [-0.1, 6.4] 3.9 [0.6, 9.5] 6.4 [1.5, 15] 8.9 [2.2, 21.9] <0.001‡
Discharge to Care Facility-no.(%) 187 (27) 386 (38) 417 (47) 512 (54) 724 (62) <0.001
90-day Readmission-No.(%) 112 (16) 178 (17) 193 (22) 257 (27) 346 (30) <0.001
90-day post-discharge Mortality-no.(%) 11 (2) 37 (4) 49 (6) 71 (7) 186 (16) <0.001
365-day post-discharge Mortality-no.(%) 35 (5) 77 (8) 103 (12) 142 (15) 320 (27) <0.001
Data presented as n (%) unless otherwise indicated. P determined by chi-square except for † determined by ANOVA or ‡ determined by Kruskal-Wallis test.
 Acute Kidney Injury is RIFLE class injury or failure. Information on acute kidney injury available on 3,898 patients
https://doi.org/10.1371/journal.pone.0199654.t002
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Elevated RDW at hospital discharge may identify patients who are at a high risk for adverse
outcomes following hospital discharge.
Existing studies on the risk factors for non-cardiac vascular surgery outcomes focus on
short-term and in-hospital mortality and emphasize demographics, clinical variables and the
American Society of Anesthesiologist score [4, 43, 44]. Studies on post-hospital outcomes in
vascular surgery are emerging and include the identification of risk factors and consequences
of hospital readmission [45–48], surgical site infections [49] and unplanned reoperations [50].
In surgical ICU survivors, elevated RDW at hospital discharge is significantly associated with
out of hospital mortality [19].
Biomarkers of systemic inflammation are commonly elevated in vascular surgery patients
and are also correlated with elevated RDW [10–13]. Inflammation alters erythropoiesis via
increased red cell apoptosis, erythroid precursor myelosuppression, decreased erythropoietin
production, decreased iron bioavailability, and erythropoietin resistance [51–54]. In critical ill-
ness survivors erythropoiesis suppression persists in combination with hypo-active bone-
Fig 1. Coefficient plot. Plot representing crude (black) and multivariate (grey) estimates of the discharge RDW-mortality association with confidence intervals
(dashes). Multivariate estimates adjusted for age, race, patient type, Deyo-Charlson index, Number of organs with acute failure, sepsis, prior vascular surgery and
vascular surgery class.
https://doi.org/10.1371/journal.pone.0199654.g001
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marrow from ongoing inflammation [38]. Ultimately inflammation and oxidative stress alter
erythrocyte homeostasis resulting in decreased RBC survival time, greater variations in RBC
cell sizes and a higher RDW.
RDW is a widely available and cost-effective laboratory test commonly measured within a
complete blood count. Patients with an elevated RDW at hospital discharge may benefit from
more intensive follow-up regimes in the outpatient clinic and at rehabilitation. Also, discharge
RDW may be valuable as prognostic information in patient-provider discussions regarding
goals and palliative services. The low cost, wide availability, quick turn-around time, and facile
interpretation of the RDW would tend to favor its adoption over more cumbersome and sub-
jective assessments in these circumstances.
Our study may be limited by potential unmeasured confounding, residual confounding
and reverse causation. The generalizability of our results may be limited as our cohort is from
Table 3. Unadjusted and adjusted associations between RDW category and 90-day post-discharge mortality (N = 4,715).
13.3 13.3–14.0 14.0–14.7 14.7–15.8 >15.8 AUC HL-χ2





































Adjustedd 1.00 (Referent)a 1.62 (0.81, 3.26) 0.17 1.99 (1.00, 3.96) 0.049 2.36 (1.21, 4.62) 0.012 4.49 (2.34, 8.60) <0.001 0.82 0.13
Note: AUC is the area under the receiver operating characteristic curve; HL- χ2 is the Hosmer-Lemeshow χ2 goodness-of-fit test; BIC is Bayesian information criterion
a. Referent in each case is RDW13.3
b. Model 1: Estimates adjusted for age, race, patient type, Deyo-Charlson index, Number of organs with acute failure, sepsis, prior vascular surgery and vascular surgery
class.
c. Model 2: Estimates adjusted for age, race, patient type, Deyo-Charlson index, hypertension, Number of organs with acute failure, sepsis, prior vascular surgery and
vascular surgery class.
d. Model 3: Estimates adjusted for covariates in Model 1 and additionally for change in expected length of stay, malignancy and calendar quarter.
https://doi.org/10.1371/journal.pone.0199654.t003
Table 4. Unadjusted and adjusted associations between RDW category, discharge to facility and hospital readmission (N = 4,715).












Crude 1.00 (Referent)a 0.97 (0.71, 1.32) 0.83 1.13 (0.83, 1.54) 0.44 1.60 (1.19, 2.13) 0.002 2.02 (1.53, 2.66) <0.001
Adjustedb 1.00 (Referent)a 0.91 (0.66, 1.24) 0.55 0.99 (0.72, 1.37) 0.96 1.32 (0.96, 1.80) 0.084 1.53 (1.12, 2.07) 0.007
90-day hospital readmission
Crude 1.00 (Referent)a 1.09 (0.84, 1.41) 0.51 1.44 (1.12, 1.87) 0.005 1.92 (1.50, 2.46) <0.001 2.19 (1.72, 2.77) <0.001
Adjustedb 1.00 (Referent)a 1.04 (0.80, 1.35) 0.78 1.29 (0.98, 1.69) 0.066 1.61 (1.24, 2.10) <0.001 1.66 (1.27, 2.16) <0.001
Discharge to Facility
Crude 1.00 (Referent)a 1.64 (1.33, 2.02) <0.001 2.41 (1.94, 2.98) <0.001 3.16 (2.56, 3.91) <0.001 4.42 (3.60, 5.43) <0.001
Adjustedb 1.00 (Referent)a 1.26 (1.01, 1.58) 0.043 1.50 (1.19, 1.89) 0.001 1.70 (1.35, 2.15) <0.001 2.10 (1.67, 2.65) <0.001
a. Referent in each case is RDW13.3
b. Estimates adjusted for age, race, patient type, Deyo-Charlson index, Number of organs with acute failure, sepsis, prior vascular surgery and vascular surgery class.
https://doi.org/10.1371/journal.pone.0199654.t004
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two academic medical centers from the same region. The limitations of RDW include the for-
mula [RDW-CV = 1 SD (MCV × 100)], the time since blood draw and RDW determination
and RDW elevations in the context of iron, folate or B12 deficiency related anemia, as well as
Sickle cell disease, and Myelodysplastic syndrome [55]. Further, we can only include readmis-
sions to the two hospitals under study. Though these hospitals have a large regional catchment
we cannot but account for all readmissions to all hospitals. Reliance on ICD-9-CM codes to
determine covariates may underestimate the true incidence or prevalence [56]. Excluding par-
ticular variables from our a priori regression model that are associated with the outcome may
introduce bias by not adjusting for confounding of that particular variable. The strengths of
the study include large sample size, adequate study power and complete follow-up for mortal-
ity at 365 days.
Conclusion
In vascular surgery patients surviving critical illness, the red cell distribution width at hospital
discharge is a predictor of out of hospital mortality and hospital readmission. Vascular surgery
patients with elevated RDW at discharge are at high-risk for subsequent adverse outcomes.
Measuring RDW at hospital discharge is inexpensive and may provide a cost-effective way to
identify patients at high risk for subsequent adverse outcomes. This study provides support for
future vascular surgery investigations to consider adding RDW to other established predictive
models to stratify critically ill vascular surgery patients at risk for adverse events.
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